Significance of Serum Bombesin as a Tumor Marker for Small-Cell Lung Carcinoma

スポンサーリンク

概要

• 論文の詳細を見る

• Using a radioimmunoassay, we studied the significance of bombesin as a specific marker for small-cell carcinoma of the lung (SCCL). Bombesin-like immunoreactivity (BLI) was detectable in serum4of15patients with SCCL (27%), but was undetectable in serum of all 15 healthy subjects. BLI was also detectable in 7 of 31 patients with non-SCCL tumors (23%) and 4 of 31 patients with other types of lung disease (13%). The present results indicate that bombesin is unlikely to be a specific marker for the early detection of SCCL though bombesin could be formed by SCCL and its metastasis, and might be released into the circulation.

• Japan Society of Clinical Chemistryの論文

著者

• 立石 カヨ子

  大阪大学医学部中央臨床検査部

• KLEE GEORGE

  Department of Laboratory Medicine, Mayo Clinic

関連論文

• Interference of peptide binding antibiotics in urinary steroid hormone assay
• Iodinations of Cholecystokinin and Human Parathyroid Hormone for Radioimmunoassay
• Clinical Application of Hormone Enzyme Immunoassay
• Significance of Serum Bombesin as a Tumor Marker for Small-Cell Lung Carcinoma

スポンサーリンク